ERS International Congress 2021 virtual: highlights from the Paediatric Assembly.

Ardura-Garcia, Cristina; Abellan, Alicia; Cuevas-Ocaña, Sara; Freitag, Nadine; Lam, Yin Ting; Makrinioti, Heidi; Slaats, Monique; Storti, Matteo; Williams, Emma E; Dassios, Theodore; Duijts, Liesbeth; Ersu, Refika H; Fustik, Stojka; Morty, Rory E.; Proesmans, Marijke; Schramm, Dirk; Saglani, Sejal; Moeller, Alexander; Pijnenburg, Marielle W. (2022). ERS International Congress 2021 virtual: highlights from the Paediatric Assembly. ERJ Open Research, 8(2), 00643-2021. European Respiratory Society 10.1183/23120541.00643-2021

Preview

Text Ardura-Garcia_ERJOpenRes_2022.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (650kB) | Preview

In this review, Early Career Members of the European Respiratory Society (ERS) and the Chairs of the Assembly 7 – Paediatrics Groups, present the highlights in paediatric respiratory medicine from the ERS International Congress 2021. The Groups cover respiratory physiology and sleep, asthma and allergy, cystic fibrosis (CF), respiratory infection and immunology, neonatology and intensive care, epidemiology, bronchology, and lung and airway development. We here describe new developments in lung function testing and sleep disordered breathing diagnosis, early life exposures affecting pulmonary function in children and effect of COVID-19 on sleep and lung function. In paediatric asthma, we present the important role of the exposome in asthma development, and how biologics can provide better outcomes. We discuss new methods to assess distal airways in children with CF, as some details remain blind when using Lung Clearance Index. Moreover, we summarise the new ERS guidelines for bronchiectasis management in children and adolescents. We present interventions to reduce morbidity and monitor pulmonary function in newborns at risk of bronchopulmonary dysplasia and long term chronic respiratory morbidity of this disease. In respiratory epidemiology, we characterise Primary Ciliary Dyskinesia, identify early life determinants of respiratory health and describe the effect of COVID-19 preventive measures on respiratory symptoms. Also, we describe the epidemiology of interstitial lung diseases, possible consequences of tracheomalacia and a classification of diffuse alveolar haemorrhage in children. Finally, we highlight that the characterisation of genes and pathways involved in the development of a disease is essential to identify new biomarkers and therapeutic targets.

Interest & Impact

Downloads

59 since deposited on 20 Apr 2022
17 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item